Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico

被引：44

作者：

Ko, GP

Garcia, C

Jiang, ZD

Okhuysen, PC

Belkind-Gerson, J

Glass, RI

DuPont, HL

机构：

[1] Seoul Natl Univ, Sch Publ Hlth, Dept Environm Hlth,Inst Hlth & Environm, Chongno Ku, Seoul 110799, South Korea

[2] Univ Texas, Sch Publ Hlth, Houston, TX USA

[3] Baylor Coll Med, Sch Med, Houston, TX 77030 USA

[4] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico

[5] St Lukes Episcopal Hosp, Houston, TX 77030 USA

[6] Ctr Dis Control & Prevent, Atlanta, GA USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2005年 / 43卷 / 12期

关键词：

D O I：

10.1128/JCM.43.12.6126-6129.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Stool specimens from 124 international travelers with acute diarrhea were tested for the presence of enteropathogens. Noroviruses (NoVs) were the second most commonly identified enteric pathogen in diarrheal stool samples (21/124, 17%), exceeded only by enterotoxigenic Escherichia coli (50/106, 47%). This study indicates that NoV is an underappreciated cause of traveler's diarrhea.

引用

收藏

页码：6126 / 6129

页数：4

相关论文

共 25 条

[1] Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world [J].

Adachi, JA ;

Jiang, ZD ;

Mathewson, JJ ;

Verenkar, MP ;

Thompson, S ;

Martinez-Sandoval, F ;

Steffen, R ;

Ericsson, CD ;

DuPont, HL .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (12) :1706-1709

[2]

CASTILLO MDI, 1995, REV MEX FIS, V41, P1

[3] Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea [J].

Chapin, AR ;

Carpenter, CM ;

Dudley, WC ;

Gibson, LC ;

Pratdesaba, R ;

Torres, O ;

Sanchez, D ;

Belkind-Gerson, J ;

Nyquist, I ;

Kärnell, A ;

Gustafsson, B ;

Halpern, JL ;

Bourgeois, AL ;

Schwab, KJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (03) :1112-1117

[4] ORAL AZTREONAM, A POORLY ABSORBED YET EFFECTIVE THERAPY FOR BACTERIAL DIARRHEA IN UNITED-STATES TRAVELERS TO MEXICO [J].

DUPONT, HL ;

ERICSSON, CD ;

MATHEWSON, JJ ;

DELACABADA, FJ ;

CONRAD, DA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (14) :1932-1935

[5] A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea [J].

DuPont, HL ;

Jiang, ZD ;

Okhuysen, PC ;

Ericsson, CD ;

de la Cabada, FJ ;

Ke, S ;

DuPont, MW ;

Martinez-Sandoval, F .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) :805-812

[6]

DuPont HL, 1997, AM J GASTROENTEROL, V92, P1962

[7]

DUPONT HL, 1993, NEW ENGL J MED, V328, P1821, DOI 10.1056/NEJM199306243282507

[8] Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial [J].

DuPont, HL ;

Jiang, ZD ;

Ericsson, CD ;

Adachi, JA ;

Mathewson, JJ ;

DuPont, MW ;

Palazzini, E ;

Riopel, LM ;

Ashley, D ;

Martinez-Sandoval, F .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) :1807-1815

[9]

DUPONT HL, 1985, T AM CLIN CLIMAT ASS, V97, P32

[10] CIPROFLOXACIN OR TRIMETHOPRIM-SULFAMETHOXAZOLE AS INITIAL THERAPY FOR TRAVELERS DIARRHEA - A PLACEBO-CONTROLLED, RANDOMIZED TRIAL [J].

ERICSSON, CD ;

JOHNSON, PC ;

DUPONT, HL ;

MORGAN, DR ;

BITSURA, JAM ;

DELACABADA, FJ .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :216-220